Annika Åhman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Annika Åhman has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Anna Sarkadi
Department of Public Health and Caring Sciences/CHAP, Uppsala University, Sweden
4 shared publications Karin Runestam
Uppsala university Hospital, Sweden
2 shared publicationsPeter Lindgren
Department of Women's and Children's Health Uppsala University Uppsala Sweden
2 shared publicationsAnna Sarkadi
Department of Women's and Children's Health Uppsala University Uppsala Sweden
1 shared publicationChristine Rubertsson
Department of Women's and Children's Health Uppsala University Uppsala Sweden
1 shared publication- Christine Rubertsson
Department of Health Sciences, Medical Faculty, Lund University, Box 117, SE-221 00 Lund, Sweden; Department of Obstetrics and Gynecology, Skane University Hospital, Klinikgatan 12, SE-22185 Lund, Sweden; Department of Obstetrics and Gynecology, Skane University Hospital, Jan Waldenströms Gata 47, SE-214 28 Malmö, Sweden
1 shared publication
Latest Publications
- Open Access
- 1 March 2018
- Published by Elsevier in Sexual & Reproductive Healthcare
- Vol. 15, 69-76
Norwegian obstetricians’ experiences of the use of ultrasound in pregnancy management. A qualitative study
- 1 March 2018
- Published by Elsevier in Sexual & Reproductive Healthcare
- Vol. 15, 69-76
Open AccessNorwegian obstetricians’ experiences of the use of ultrasound in pregnancy management. A qualitative study
- Open Access
- 13 September 2016
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 16 (1) , 1-10
‘It made you think twice’ – an interview study of women’s perception of a web-based decision aid concerning screening and diagnostic testing for fetal anomalies
Enabling women to make informed decisions is a key objective in the guidelines governing prenatal screening and diagnostics. Despite efforts to provide information, research shows that women’s choice of prenatal screening is often not based on informed decisions. The aim of this study was to investigate pregnant women’s perceptions of the use of an interactive web-based DA, developed to initiate a process of reflection and deliberate decision-making concerning screening and testing for fetal anomalies. A qualitative study was applied and individual interviews were conducted. Seventeen pregnant women attending antenatal healthcare in Uppsala County, Sweden, who had access to the decision aid were interviewed. Eleven opted to use the decision aid and six did not. Data were analysed by systematic text condensation. Women appreciated the decision aid, as it was easily accessible; moreover, they emphasised the importance of a reliable source. It helped them to clarify their own standpoints and engaged their partner in the decision-making process. Women described the decision aid as enhancing their awareness that participating in prenatal screening and diagnostics was a conscious choice. Those who chose not to use the web-based decision aid when offered reported that they already had sufficient knowledge. The decision aid was able to initiate a process of deliberate decision-making in pregnant women as a result of their interaction with the tool. Access to a web-based decision aid tool can be valuable to expectant parents in making quality decisions regarding screening for fetal anomalies.
- 13 September 2016
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 16 (1) , 1-10
Open Access‘It made you think twice’ – an interview study of women’s perception of a web-based decision aid concerning screening and diagnostic testing for fetal anomalies
Enabling women to make informed decisions is a key objective in the guidelines governing prenatal screening and diagnostics. Despite efforts to provide information, research shows that women’s choice of prenatal screening is often not based on informed decisions. The aim of this study was to investigate pregnant women’s perceptions of the use of an interactive web-based DA, developed to initiate a process of reflection and deliberate decision-making concerning screening and testing for fetal anomalies. A qualitative study was applied and individual interviews were conducted. Seventeen pregnant women attending antenatal healthcare in Uppsala County, Sweden, who had access to the decision aid were interviewed. Eleven opted to use the decision aid and six did not. Data were analysed by systematic text condensation. Women appreciated the decision aid, as it was easily accessible; moreover, they emphasised the importance of a reliable source. It helped them to clarify their own standpoints and engaged their partner in the decision-making process. Women described the decision aid as enhancing their awareness that participating in prenatal screening and diagnostics was a conscious choice. Those who chose not to use the web-based decision aid when offered reported that they already had sufficient knowledge. The decision aid was able to initiate a process of deliberate decision-making in pregnant women as a result of their interaction with the tool. Access to a web-based decision aid tool can be valuable to expectant parents in making quality decisions regarding screening for fetal anomalies.
- 21 February 2014
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 93 (4) , 367-373
Ultrasonographic fetal soft markers in a low‐risk population: prevalence, association with trisomies and invasive tests
Objective: To investigate the prevalence of soft markers identified at second trimester ultrasound in a low‐risk population and the association of these markers with trisomies and invasive testing.Design: Prospective observational study.Setting: Swedish University Hospital.Population: All women with fetuses examined by ultrasound at 15+0–22+0 weeks gestation between July 2008 and March 2011.Methods: Cases with soft markers were compared with non‐cases with regard to trisomies and invasive testing.Main outcome measures: Prevalence of soft markers, likelihood ratio for trisomies and risk ratio for invasive tests after detection of soft markers.Results: Second trimester ultrasound was performed on 10 710 fetuses. Markers were detected in 5.9% of fetuses. 5.1% were isolated, 0.7% were multiple and 0.1% were combined with an anomaly. Presence of markers showed a positive likelihood ratio for Down syndrome, but the association (likelihood ratio = 7.1) was only statistically significant for the combined category of any marker (isolated, multiple or combined with anomaly). The risk ratio for invasive testing after the second trimester ultrasound was 24.0 in pregnancies with isolated soft markers compared with those without markers.Conclusion: In a low‐risk population, soft markers were found in 5.9% of fetuses at second trimester ultrasound. The likelihood ratio for Down syndrome was significant only for any marker (isolated, multiple or combined with anomaly). The presence of soft markers increased the incidence of invasive procedures substantially. Soft markers should be noted when information on second trimester ultrasound is formulated, and all units performing fetal ultrasound examinations should have established routines concerning information management when soft markers are identified.
- 21 February 2014
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 93 (4) , 367-373
Ultrasonographic fetal soft markers in a low‐risk population: prevalence, association with trisomies and invasive tests
Objective: To investigate the prevalence of soft markers identified at second trimester ultrasound in a low‐risk population and the association of these markers with trisomies and invasive testing.Design: Prospective observational study.Setting: Swedish University Hospital.Population: All women with fetuses examined by ultrasound at 15+0–22+0 weeks gestation between July 2008 and March 2011.Methods: Cases with soft markers were compared with non‐cases with regard to trisomies and invasive testing.Main outcome measures: Prevalence of soft markers, likelihood ratio for trisomies and risk ratio for invasive tests after detection of soft markers.Results: Second trimester ultrasound was performed on 10 710 fetuses. Markers were detected in 5.9% of fetuses. 5.1% were isolated, 0.7% were multiple and 0.1% were combined with an anomaly. Presence of markers showed a positive likelihood ratio for Down syndrome, but the association (likelihood ratio = 7.1) was only statistically significant for the combined category of any marker (isolated, multiple or combined with anomaly). The risk ratio for invasive testing after the second trimester ultrasound was 24.0 in pregnancies with isolated soft markers compared with those without markers.Conclusion: In a low‐risk population, soft markers were found in 5.9% of fetuses at second trimester ultrasound. The likelihood ratio for Down syndrome was significant only for any marker (isolated, multiple or combined with anomaly). The presence of soft markers increased the incidence of invasive procedures substantially. Soft markers should be noted when information on second trimester ultrasound is formulated, and all units performing fetal ultrasound examinations should have established routines concerning information management when soft markers are identified.
- 1 October 2010
- Published by Elsevier in Patient Education and Counseling
- Vol. 81 (1) , 87-93
Did I really want to know this? Pregnant women's reaction to detection of a soft marker during ultrasound screening
- 1 October 2010
- Published by Elsevier in Patient Education and Counseling
- Vol. 81 (1) , 87-93
Did I really want to know this? Pregnant women's reaction to detection of a soft marker during ultrasound screening
- 1 January 2010
- Published by American Psychological Association (APA)
Ultrasound Soft Markers Interview Guide
- 1 January 2010
- Published by American Psychological Association (APA)
Ultrasound Soft Markers Interview Guide